Cellares
PrivateLast Round
Series D
Jun 18, 2026
Est. Valuation
$1.44B
Total Funding Raised
$1.01B
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cellares is a biotechnology company that provides integrated development and manufacturing solutions for cell therapies through its automated IDMO Smart Factory network.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Biotech Equipment, Warehouse Automation
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellares Comparables
Compare Cellares with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ori Biotech | 83% | |
| Cellular Origins | 81% | |
| Miltenyi Biotec | 80% | |
Cellares Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 18, 2026 | ||||
| Series D | Jan 28, 2026 | ||||
| IPO | Dec 1, 2025 | ||||
| Series C | Aug 23, 2023 | ||||
| Series B | May 5, 2021 | ||||
Series A | Aug 1, 2019 |
Key People
Founding team and executive leadership
Cellares Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series A |
| Prime Radiant Partners | Series D |
| S32 | Series C |
| Skyviews Life Science | Series B |
| Duquesne Family Office | Series D |
| Koch-ventures.com | Series C |
| EDBI | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
$257M round raised
- Jan 30, 2026
$600 million investment into automated smart factories.
Cellares Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cellares's valuation, stock price, and market status.